溃疡性结肠炎临床病例回顾性分析(2)
 |
| 第1页 |
参见附件。
参考文献
[1]中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见.中华内科杂志，2012，51：818-831.
[2]Truelove SC，Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ 1955；2：1041–1048.
[3]D'Haens G，Sandborn WJ，Feagan BG，Geboes K，Hanauer SB，Irvine EJ，Lémann M，Marteau P，Rutgeerts P，Sch？lmerich J，Sutherland LR. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007；132(2)：763-86.
[4]中国炎症性肠病协作组，3100例溃疡性结肠炎住院病例回顾分析〔J〕. 中华消化杂志，2006，26(6)：368-372.
[5]Jakubowski A，Zagórowicz E，Kraszewska E，Bartnik W. Rising hospitalization rates for inflammatory bowel disease in Poland. Pol Arch Med Wewn.2014；124(4)：180-90.
[6]Nguyen GC，Tuskey A，Dassopoulos T，Harris ML，Brant SR. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis. 2007；13(12)：1529-35.
[7]Jess T，Riis L，Vind I，Winther KV，Borg S，Binder V，Langholz E，Thomsen O？，Munkholm P. Changes in clinical characteristics，course，and prognosis of inflammatory bowel disease during the last 5 decades： a population-based study from Copenhagen，Denmark. Inflamm Bowel Dis. 2007；13(4)：481-9.
[8]Zenlea T，Peppercorn MA. Immunosuppressive therapies for inflammatory bowel disease. World J Gastroenterol. 2014 Mar 28；20(12)：3146-52.
[9]Eaden JA，Abrams KR，Mayberry JF. The risk of colorectal cancer in ulcerative colitis： a meta-analysis. Gut，2001，48(4)：526-535.
您现在查看是摘要介绍页，详见PDF附件。